LEPR and diabetes mellitus: Although the LepR(+) phenotype is not investigated in skeletal muscle (yet), CD140a(+)/Sca1(−) is likely to be a corresponding subpopulation accompanying fatty degeneration secondary to metabolic ECM changes in patients with diabetes and obesity.